Tulang, Baby Boy .

HRN: 24-45-05  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2024
AMPICILLIN 250MG (VIAL)
01/20/2024
01/27/2024
IV
115
Q12
PSNB
Waiting Final Action 
01/20/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
01/20/2024
01/27/2024
IV
16mg
Q24
PSNB
Waiting Final Action 
01/22/2024
CEFOTAXIME 500MG (VIAL)
01/22/2024
01/29/2024
IV DRIP
115mg
Q12
PSNB
Waiting Final Action 
01/22/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/22/2024
01/29/2024
SLOW IVTT
35mg
Q24
PSNB
Waiting Final Action 
01/25/2024
MUPIROCIN 2%, 15G (TUBE)
01/25/2024
02/01/2024
TOPICAL
15g
TID
PSNB
Waiting Final Action 
01/27/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
01/27/2024
02/02/2024
IV
28mg As LD Then 14mg As MD
OD
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: